Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

This publication has 25 references indexed in Scilit:

• High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes
  Seminars in Radiation Oncology, 2002
• Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2002
• Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques
  Cancer, 2001
• Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 2001
• The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma
  Radiotherapy and Oncology, 2000
• Five-year disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance
  International Journal of Radiation Oncology*Biology*Physics, 1998
• High dose-rate afterloading 192iridium prostate brachytherapy: feasibility report
  International Journal of Radiation Oncology*Biology*Physics, 1998